Introduction {#S1}
============

Microbial natural products and their derivatives have been an important source of new antibiotics required for the treatment of infectious diseases ([@B19]). Since the first antibiotic, penicillin, was discovered from the fungus *Penicillium notatum* in 1928 ([@B19]), multiple classes of anti-infectives have been isolated from a variety of fungi, such as gliotoxin, beauvericin, and roquefortine C ([@B9]). However, the rapid evolution of antimicrobial resistance in both hospital and community settings is decreasing the efficacy of our current therapies and causing a serious global public health crisis ([@B1]; [@B2]). One strategy to combat antimicrobial resistance is to discover and develop novel antimicrobial drugs that are not subject to existing resistance mechanisms ([@B5]; [@B22]). Fungi-derived natural products hold great promise in the search for new therapies.

Ophiobolins, which represent a minor group of sesterterpenes featuring a tricyclic (5-8-5 fused) or tetracyclic (5-8-5-5 spiro-fused) skeleton, are reported to show a broad spectrum of inhibitory activities against nematodes, HMG-CoA reductase, fungi, and bacteria; cytotoxic activity against multiple cancer cells; and anti-inflammatory activity against lipopolysaccharide-induced nitric oxide production ([@B18]; [@B14]), and this member of natural products is widely discovered in the species of *Bipolaris*. As a part of our ongoing program for exploring new antimicrobial agents from fungi, the fungus *Bipolaris* species TJ403-B1 attracted our attention and was systematically studied ([@B12], [@B13]). Following a further chemical investigation on the EtOAc extract of the title fungus, six previously undescribed ophiobolin-type sesterterpenes, namely, bipolatoxins A--F (**1**--**6**); and one previously undescribed pimarane-type diterpene, namely, 1β-hydroxy momilactone A (**7**); together with three known compounds (**8**--**10**); were isolated and identified. Herein, the detailed isolation, structure identification, and antimicrobial activity of these compounds ([Figure 1](#F1){ref-type="fig"}) are described.

![Chemical structures of compounds **1**--**10**.](fmicb-11-00856-g001){#F1}

Materials and Methods {#S2}
=====================

General Experimental Procedures {#S2.SS1}
-------------------------------

An X-5 microscopic melting point apparatus (Beijing Tech, Beijing, China) was used, and the reported melting points were uncorrected. Optical rotations were measured in MeOH on a Perkin-Elmer 341 polarimeter (PerkinElmer, Waltham, MA, United States). Infrared (IR) spectra were acquired on a Bruker Vertex 70 FT-IR instrument (Bruker, Karlsruhe, Germany). UV spectra were measured on a Varian Cary 50 spectrometer (Varian, Salt Lake City, UT, United States). Circular dichroism (CD) data were collected from a JASCO J-810 spectrometer (JASCO Co., Ltd., Tokyo, Japan). 1D and 2D nuclear magnetic resonance (NMR) spectra were acquired on a Bruker AM-400, a DRX-600, and a Bruker AM-800 instrument, and the ^1^H and ^13^C NMR chemical shifts were referenced to the solvent impurity peaks for methanol-*d*~4~ (δ~H~ 3.31 and δ~C~ 49.0) and acetone-*d*~6~ (δ~H~ 2.05 and δ~C~ 206.3). High-resolution electrospray ionization mass spectroscopy (HRESIMS) was performed on a Thermo Fisher LC-LTQ-Orbitrap XL spectrometer (Thermo Fisher, Palo Alto, CA, United States). Semipreparative high-performance liquid chromatography (HPLC) was performed using a Dionex Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, United States) with an UV detector and an Ultimate XB-C~18~ (10 × 250 mm, 5 μm, Welch Ultimate XB-C~18~) column. Silica gel (100--200 mesh and 200--300 mesh; Qingdao Marine Chemical Inc., Qingdao, China), ODS (50 μm; YMC, Kyoto, Japan), and Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden) were used for column chromatography (CC). Thin-layer chromatography was performed with RP-C~18~ F~254~ plates (Merck, Darmstadt, Germany) and silica gel 60 F~254~ (Yantai Chemical Industry Research Institute, Yantai, China).

Fungus Material {#S2.SS2}
---------------

The fungal strain in our project was obtained from the leaves of wheat, which was collected from Wuhan City of Hubei Province, China, in May 2016. Sequence data for this fungal strain have been submitted to the DDBJ/EMBL/GenBank under accession no. [MH545913](MH545913). A voucher sample has been preserved in the culture collection center of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).

Cultivation, Extraction, and Isolation {#S2.SS3}
--------------------------------------

The fungal strain was cultured on potato dextrose agar at 28 °C for 5 days to prepare the seed cultures. Then, the agar plugs were inoculated into 450 Erlenmeyer flasks (1 L), previously sterilized by autoclaving, each containing 250 g rice and 250 mL distilled water. All flasks were incubated at 28 °C for 28 days. The fermented rice substrate was extracted five times in 95% aqueous EtOH at room temperature, and the solvent was evaporated under vacuum to afford a residue. The residue was suspended in H~2~O and successively partitioned with EtOAc to yield a total extract.

The EtOAc extract (300 g) was subjected to RP-C~18~ silica gel CC with a stepwise gradient of MeOH--H~2~O (20, 40, 60, 80, and 100%) to afford five major fractions, A--E. Fraction C (40 g) was applied to a silica gel column eluted with petroleum ether--EtOAc (10:0 to 0:1, vol/vol) to furnish eight main fractions, C1--C8. Fraction C4 (11.3 g) was chromatographed on Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and further purified on an RP-C~18~ silica gel column eluted with MeOH--H~2~O (40:60 to 60:40, vol/vol) to obtain fractions C4.1--C4.12. Fraction C4.5 (3.0 g) was applied to silica gel CC eluted with stepwise CH~2~Cl~2~--MeOH (1:0--100:1, vol/vol) to afford nine fractions (C4.5.1--C4.5.9). Fraction C4.5.2 was repeatedly separated via Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and then separated by semipreparative HPLC (CH~3~CN--H~2~O, 73:27, vol/vol, 3.0 mL/min) to afford compound **10** (*t*~R~ 34.2 min, 11.2 mg). Purification of fraction C4.5.3 by semipreparative HPLC (MeOH--H~2~O, 80:20, vol/vol, 3.0 mL/min) afforded compound **6** (*t*~R~ 16.2 min, 4.1 mg). Purification of fraction C4.5.4 by semipreparative HPLC (CH~3~CN--H~2~O, 70:30, vol/vol, 3.0 mL/min) afforded compound **7** (*t*~R~ 11.2 min, 3.2 mg). Fraction C4.5.6 was repeatedly separated via Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and then purified by semipreparative HPLC (MeOH--H~2~O, 78:22, vol/vol, 3.0 mL/min) to afford compound **4** (*t*~R~ 31.2 min, 2.2 mg). Fraction C4.5.7 was repeatedly separated via Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and then purified by semipreparative HPLC (MeOH--H~2~O, 75:25, vol/vol, 3.0 mL/min) to afford compound **5** (*t*~R~ 30.9 min, 1.0 mg). Fraction C4.5.9 was repeatedly separated via Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and then purified by semipreparative HPLC (CH~3~CN--H~2~O, 60:40, vol/vol, 3.0 mL/min) to afford compound **3** (*t*~R~ 34.9 min, 4.8 mg). Fraction C4.7 (500 mg) was applied to silica gel CC eluted with stepwise CH~2~Cl~2~--MeOH (1:0--60:1, vol/vol) to afford six fractions (C4.7.1--C4.7.6). Purification of fraction C4.7.3 by semipreparative HPLC (MeOH--H~2~O, 77:23, vol/vol, 3.0 mL/min) afforded compound **1** (*t*~R~ 30.9 min, 6.3 mg). Purification of fraction C4.7.4 by semipreparative HPLC (MeOH--H~2~O, 83:17, vol/vol, 3.0 mL/min) afforded compound **2** (*t*~R~ 31.0 min, 4.5 mg). Fraction C5 (4.1 g) was separated on Sephadex LH-20 CC (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and further purified by RP-C~18~ silica gel CC (MeOH--H~2~O, 40:60 to 60:40, vol/vol) to afford three main fractions, C5.1--C5.3. Compound **8** (*t*~R~ 34.8 min, 10.6 mg) was purified by semipreparative HPLC (MeOH--H~2~O, 71:29, vol/vol, 3.0 mL/min) from fraction C5.2. Fraction C6 (2.2 g) was chromatographed on Sephadex LH-20 (CH~2~Cl~2~--MeOH, 1:1, vol/vol) and further purified by semipreparative HPLC (MeOH--H~2~O, 70:30, vol/vol, 3.0 mL/min) to afford compound **9** (*t*~R~ 39.3 min, 4.5 mg).

Bipolatoxin A (**1**). Colorless needle crystals; ${\lbrack\alpha\rbrack}_{D}^{25}$: +70 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 202 (4.11), 229 (4.07) nm; ECD (*c* 0.18, MeOH) = Δε~219~ +3.07, Δε~313~ −0.70; IR ν~max~ = 3,428, 2,935, 1,682, 1,622, 1,459, 1,379, 1,317, 1,227, 1,186, 1,028, 855 cm^--1^; HRESIMS *m*/*z* 409.2729 \[M+Na\]^+^ (calcd for C~25~H~38~O~3~Na^+^, 409.2713). For ^1^H and ^13^C NMR data, see [Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

^1^H NMR assignments for compounds **1--4** (δ in ppm and *J* in Hz).

  No.   1^a,b^                              2^a,b^                        3^a,b^                        4^b,c^
  ----- ----------------------------------- ----------------------------- ----------------------------- -----------------------------
  1     1.17 t (13.0); 2.10 m               1.16 t (13.1); 2.10 m         1.36 t (13.2); 2.20 m         1.41 m; 1.50 m
  2     2.95 d (13.0)                       2.95 d (13.2)                 2.93 d (13.1)                 2.05 ddd (4.1, 9.5, 13.2)
  4     5.92 t (1.5)                        5.93 t (1.5)                  5.97 t (1.5)                  1.88 m; 2.19 m
  5                                                                                                     4.99 t (6.4)
  6     3.61 d (3.3)                        3.61 d (3.3)                  3.51 d (3.0)                  3.72 ddd (2.4, 6.9, 9.6)
  8     5.73 m                              5.73 d (5.9)                  5.75 d (4.8)                  6.88 dt (2.4, 8.4)
  9     2.00 m; 2.39 d (18.7)               2.02 m; 2.39 d (18.7)         1.96 m; 2.69 d (15.6)         2.17 m; 2.40 dd (8.9, 12.8)
  10    2.71 ddd (3.4, 9.9, 14.1)           2.71 ddd (3.5, 9.9, 14.0)     3.22 d (13.6)                 1.81 m
  12    1.45 m; 1.51 m                      1.45 dt (5.1, 11.9); 1.52 m   2.19 m; 2.34 dq (2.4, 15.9)   1.41 m; 1.69 dd (4.1, 14.4)
  13    1.32 m; 1.52 m                      1.34 dt (5.2, 11.8); 1.53 m   5.32 t (2.0)                  1.52 m; 1.55 m
  14    1.84 m                              1.83 m                                                      2.46 m
  15    1.55 m                              1.57 m                        2.25 m                        1.80 m
  16    1.71 ddd (6.3, 8.8, 14.9); 2.20 m   1.76 m; 2.24 d (18.4)         1.92 m; 2.20 m                1.90 m; 1.96 dt (6.2, 13.2)
  17    5.60 m                              5.62 ddd (6.3, 7.8, 15.7)     5.57 m                        5.59 m
  18    5.59 s                              5.40 d (15.8)                 5.57 s                        5.59 s
  20    2.09 s                              2.10 s                        2.13 s                        1.21 s
  21    3.90 d (12.2); 4.30 m               3.90 d (12.3); 4.30 m         3.94 d (12.4); 4.28 m         
  22    1.07 s                              1.08 s                        1.10 s                        0.99 s
  23    0.90 d (6.6)                        0.91 d (6.6)                  1.09 d (6.8)                  0.84 d (6.8)
  24    1.26 s                              1.25 s                        1.25 d (1.5)                  1.27 s
  25    1.26 s                              1.25 s                        1.25 d (1.5)                  1.27 s
  OMe                                       3.14 s                                                      
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"m" means overlapped or multiplet with other signals.
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.

Bipolatoxin B (**2**). Colorless oil; ${\lbrack\alpha\rbrack}_{D}^{25}$: +65 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 202 (4.09), 229 (4.02) nm; ECD (*c* 0.18, MeOH) = Δε~218~ +1.82, Δε~314~ −1.14; IR ν~max~ = 3,430, 2,935, 1,684, 1,621, 1,458, 1,378, 1,315, 1,257, 1,171, 1,145, 1,075, 1,027, 977, 857, 815, 616 cm^--1^; HRESIMS *m/z* 423.2882 \[M+Na\]^+^ (calcd for C~26~H~40~O~3~Na^+^, 423.2870); ^1^H and ^13^C NMR data, see [Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}.

Bipolatoxin C (**3**). Colorless oil; ${\lbrack\alpha\rbrack}_{D}^{25}$: −3 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 203 (4.14), 229 (3.93) nm; ECD (*c* 0.18, MeOH) = Δε~206~ −15.45, Δε~222~ +1.85, Δε~308~ −2.30; IR ν~max~ = 3,403, 2,955, 2,933, 2,876, 1,627, 1,516, 1,453, 1,382, 1,343, 1,271, 1,232, 1,172, 1,122, 1,028, 962, 927, 869, 825, 626 cm^--1^; HRESIMS *m/z* 407.2550 \[M+Na\]^+^ (calcd for C~25~H~36~O~3~Na^+^, 407.2557); ^1^H and ^13^C NMR data, see [Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}.

Bipolatoxin D (**4**). Colorless needle crystals; ${\lbrack\alpha\rbrack}_{D}^{25}$: +30 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 202 (3.99), 226 (4.07) nm; ECD (*c* 0.18, MeOH) = Δε~223~ −10.12, Δε~248~ +3.93; IR ν~max~ = 3,430, 2,931, 2,851, 1,733, 1,681, 1,638, 1,458, 1,384, 1,315, 1,217, 1,181, 1,150, 1,099, 1,028, 934, 907, 832, 764 cm^--1^; HRESIMS *m/z* 425.2653 \[M+Na\]^+^ (calcd for C~25~H~38~O~4~Na^+^, 425.2662); ^1^H and ^13^C NMR data, see [Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}.

Bipolatoxin E (**5**). Colorless oil; ${\lbrack\alpha\rbrack}_{D}^{25}$: −91 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 203 (4.24) nm; ECD (*c* 0.18, MeOH) = Δε~219~ −8.49, Δε~246~ +3.19; IR ν~max~ = 3,427, 2,966, 2,925, 2,853, 1,731, 1,675, 1,631, 1,579, 1,452, 1,384, 1,349, 1,307, 1,290, 1,248, 1,221, 1,130, 1,096, 1,027, 939, 835, 760, 653, 618, 580 cm^--1^; HRESIMS *m/z* 423.2500 \[M+Na\]^+^ (calcd for C~25~H~36~O~4~Na^+^, 423.2506); ^1^H and ^13^C NMR data, see [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

^1^H NMR assignments for compounds **5--7** (δ in ppm and *J* in Hz).

  No.   5^a,b^                                            6^b,c^                        7^b,d^
  ----- ------------------------------------------------- ----------------------------- ------------------------------------------
  1     1.59 m; 1.99 m                                    5.66 s                        4.18 dd (7.3, 9.3)
  2     2.04 ddd (4.3, 9.6, 12.5)                                                       2.41 dd (9.3, 19.3); 2.86 dd (7.3, 19.3)
  3                                                       2.47 q (7.2)                  
  4     1.89 m; 2.21 d (14.8)                             1.57 m; 1.82 m                
  5     5.00 dd (5.7, 7.1)                                1.72 m; 2.25 m                2.52 d (5.1)
  6     3.75 ddd (2.5, 7.2, 9.6)                          3.83 d (8.0)                  5.04 t (5.1)
  7                                                                                     5.72 dd (1.3, 5.1)
  8     6.88 dt (2.5, 8.4)                                6.41 t (8.3)                  
  9     2.16 ddd (8.0, 11.3, 13.1); 2.54 dd (8.9, 13.0)   2.25 m; 2.65 dt (8.6, 14.0)   2.10 m
  10    2.28 m                                            1.90 m                        
  11                                                                                    1.47 m; 2.03 m
  12    4.23 m                                            3.73 dd (6.6, 11.4)           1.55 dq (2.6, 13.4); 1.62 dt (4.1, 13.2)
  13    5.31 m                                            1.41 t (11.6); 1.72 m         
  14                                                      2.25 m                        2.07 m; 2.26 d (11.8)
  15    2.24 m                                            1.78 m                        5.91 dd (10.8, 17.5)
  16    1.25 m; 1.52 m                                    1.30 d (8.3); 1.41 t (11.6)   4.91 dd (1.3, 10.7); 5.01 dd (1.3, 17.5)
  17    1.99 m                                            2.25 m                        0.93 s
  18    5.15 m                                            6.77 m                        1.46 s
  20    1.26 s                                            1.10 d (6.9)                  0.93 s
  22    0.94 s                                            1.08 s                        
  23    1.07 d (6.7)                                      0.89 d (6.7)                  
  24    1.62 s                                            1.82 s                        
  25    1.70 s                                                                          
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###### 

^13^C NMR assignments for compounds **1--7**.

  No.   1^a^         2^a^         3^a^         4^b^         5^c^         6^a^         7^d^
  ----- ------------ ------------ ------------ ------------ ------------ ------------ -------------
  1     47.5 CH~2~   47.5 CH~2~   47.5 CH~2~   44.4 CH~2~   32.3 CH~2~   131.3 CH     68.2 CH
  2     52.4 CH      52.3 CH      53.1 CH      53.4 CH      53.6 CH      155.4 C      45.8 CH~2~
  3     183.1 C      183.1 C      183.5 C      80.9 C       80.9 C       40.9 CH      204.4 C
  4     130.6 CH     130.6 CH     130.9 CH     47.0 CH~2~   46.9 CH~2~   34.1 CH~2~   54.6 C
  5     212.0 C      212.0 C      212.1 C      84.0 CH      84.0 CH      30.4 CH~2~   44.8 CH
  6     53.7 CH      53.7 CH      53.8 CH      45.8 CH      46.0 CH      41.8 CH      73.8 CH
  7     135.1 C      135.2 C      135.9 C      132.9 C      133.8 C      141.9 C      115.1 CH
  8     130.7 CH     130.6 CH     129.7 CH     141.4 CH     140.3 CH     139.2 CH     148.8 C
  9     30.4 CH~2~   30.4 CH~2~   31.6 CH~2~   25.6 CH~2~   24.5 CH~2~   24.3 CH~2~   48.0 CH
  10    44.3 CH      44.3 CH      52.1 CH      55.7 CH      58.0 CH      47.3 CH      38.4 C
  11    45.9 C       45.9 C       46.2 C       44.9 C       54.2 C       50.5 C       24.0 CH~2~
  12    45.6 CH~2~   45.6 CH~2~   51.3 CH~2~   37.6 CH~2~   84.6 CH      80.3 CH      38.0 CH~2~
  13    27.9 CH~2~   27.9 CH~2~   121.1 CH     23.9 CH~2~   125.9 CH     31.3 CH~2~   41.0 C
  14    52.0 CH      52.1 CH      151.2 C      46.4 CH      151.4 C      41.4 CH      48.2 CH~2~
  15    33.6 CH      33.5 CH      33.3 CH      34.9 CH      32.7 CH      33.8 CH      150.4 CH
  16    41.1 CH~2~   41.3 CH~2~   39.0 CH~2~   41.1 CH~2~   36.6 CH~2~   37.1 CH~2~   110.2 CH~2~
  17    126.3 CH     130.4 CH     125.5 CH     127.0 CH     26.3 CH~2~   27.8 CH~2~   22.2 CH~3~
  18    140.6 CH     137.4 CH     140.9 CH     140.4 CH     125.5 CH     143.6 CH     21.2 CH~3~
  19    71.1 C       76.4 C       71.1 C       71.1 C       132.6 C      129.2 C      174.7 C
  20    17.5 CH~3~   17.5 CH~3~   17.5 CH~3~   25.5 CH~3~   25.5 CH~3~   22.8 CH~3~   15.2 CH~3~
  21    67.0 CH~2~   67.0 CH~2~   66.5 CH~2~   174.5 C      174.4 C      173.4 C      
  22    23.4 CH~3~   23.4 CH~3~   22.6 CH~3~   18.9 CH~3~   12.5 CH~3~   14.6 CH~3~   
  23    19.0 CH~3~   19.1 CH~3~   18.7 CH~3~   17.3 CH~3~   18.9 CH~3~   17.0 CH~3~   
  24    30.0 CH~3~   26.2 CH~3~   30.0 CH~3~   30.0 CH~3~   17.8 CH~3~   12.5 CH~3~   
  25    30.1 CH~3~   26.3 CH~3~   30.1 CH~3~   30.0 CH~3~   25.9 CH~3~   172.1 C      
  OMe                50.5 CH~3~                                                       
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Bipolatoxin F (**6**). Colorless oil; ${\lbrack\alpha\rbrack}_{D}^{25}$: −16 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) = 204 (4.21) nm; ECD (*c* 0.18, MeOH) = Δε~237~ −4.09; IR ν~max~ = 3,435, 2,950, 2,874, 1,687, 1,639, 1,460, 1,452, 1,385, 1,266, 1,203, 1,159, 1,106, 1,027, 664 cm^--1^; HRESIMS *m/z* 439.2453 \[M+Na\]^+^ (calcd for C~25~H~36~O~5~Na^+^, 439.2455); ^1^H and ^13^C NMR data, see [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

1β-Hydroxy momilactone A (**7**). Colorless oil; ${\lbrack\alpha\rbrack}_{D}^{25}$: −256 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) 203 (4.11) nm; ECD (*c* 0.18, MeOH) = Δε~201~ −19.50, Δε~293~ −1.89; IR ν~max~ = 3,511, 3,431, 3,082, 2,922, 1,756, 1,698, 1,635, 1,457, 1,414, 1,378, 1,338, 1,195, 1,149, 1,093, 988, 908, 864, 772, 747, 647 cm^--1^; HRESIMS *m*/*z* 331.1913 \[M+H\]^+^ (calcd for C~20~H~27~O~4~^+^, 331.1904); ^1^H and ^13^C NMR data, see [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

X-Ray Crystal Structure Analysis {#S2.SS4}
--------------------------------

The suitable crystals of compounds **1**, **4**, and **8** were acquired from MeOH--H~2~O (20:1, vol/vol) at room temperature. The intensity data were recorded on an XtaLAB PRO MM007HF diffractometer (Cu Kα). Using Olex2 ([@B6]), the structures were solved via direct methods with SHELXL-2014/7 ([@B16]). Refinements were executed by the SHELXL-2014/7 refinement package via means of full-matrix least squares on *F*^2^, and the anisotropic displacement parameters were applied for all the non-hydrogen atoms. All the hydrogen atoms were placed on the calculated positions and refined by a riding model. The crystallographic data for these structures were deposited in the Cambridge Crystallographic Data Center (CCDC 1971181 for **1**, CCDC 1913829 for **4**, and CCDC 1913832 for **8**). Copies of the data can be obtained free of charge on application to CCDC (Cambridge, United Kingdom; e-mail: <deposi@ccdc.cam.ac.uk>).

*Crystallographic data for compound* ***1***: C~25~H~38~O~3~, *M* = 386.55, orthorhombic, *a* = 5.92122(10) Å, *b* = 15.67980(10) Å, *c* = 26.2277(2) Å, α = 90.00°, β = 90.00°, γ = 90.00°, *V* = 2435.07(5) Å^3^, *T* = 100(1) K, space group *P*2~1~2~1~2~1~, *Z* = 4, μ(Cu Kα) = 0.523 mm^--1^, 24,079 reflections measured, 4,861 independent reflections (*R*~*int*~ = 0.0218). The final *R*~1~ values were 0.0293 \[*I* \> 2σ(*I*)\]. The final *wR*(*F*^2^) values were 0.0772 \[*I* \> 2σ(*I*)\]. The final *R*~1~ values were 0.0296 (all data). The final *wR*(*F*^2^) values were 0.0774 (all data). The goodness of fit on *F*^2^ was 1.032. Flack parameter = 0.08(3) ([Supplementary Data Sheets S1](#DS1){ref-type="supplementary-material"}, [S4](#DS4){ref-type="supplementary-material"}).

*Crystallographic data for compound* ***4***: C~25~H~38~O~4~⋅2H~2~O, *M* = 438.58, monoclinic, *a* = 14.63410(10) Å, *b* = 6.02160(10) Å, *c* = 14.70210(10) Å, α = 90.00°, β = 111.0790(10)°, γ = 90.00°, *V* = 1,208.87(2) Å^3^, *T* = 100.00(10) K, space group *P*2~1~, *Z* = 2, μ(Cu Kα) = 0.678 mm^--1^, 25,163 reflections measured, 4,543 independent reflections (*R*~*int*~ = 0.0536). The final *R*~1~ values were 0.0337 \[*I* \> 2σ(*I*)\]. The final *wR*(*F*^2^) values were 0.0879 \[*I* \> 2σ(*I*)\]. The final *R*~1~ values were 0.0352 (all data). The final *wR*(*F*^2^) values were 0.0886 (all data). The goodness of fit on *F*^2^ was 1.072. Flack parameter = 0.05(10) ([Supplementary Data Sheets S2](#DS2){ref-type="supplementary-material"}, [S4](#DS4){ref-type="supplementary-material"}).

*Crystallographic data for compound* ***8***: C~25~H~36~O~4~, *M* = 400.54, monoclinic, *a* = 11.94134(9) Å, *b* = 6.14791(4) Å, *c* = 15.49296(12) Å, α = 90.00°, β = 101.4154(7)°, γ = 90.00°, *V* = 1114.904(15) Å^3^, *T* = 100(2) K, space group *P*2~1~, *Z* = 2, μ(Cu Kα) = 0.626 mm^--1^, 23,169 reflections measured, 4,453 independent reflections (*R*~*int*~ = 0.0341). The final *R*~1~ values were 0.0291 \[*I* \> 2σ(*I*)\]. The final *wR*(*F*^2^) values were 0.0765 \[*I* \> 2σ(*I*)\]. The final *R*~1~ values were 0.0301 (all data). The final *wR*(*F*^2^) values were 0.0772 (all data). The goodness of fit on *F*^2^ was 1.026. Flack parameter = −0.16(6) ([Supplementary Data Sheets S3](#DS3){ref-type="supplementary-material"}, [S4](#DS4){ref-type="supplementary-material"}).

Antimicrobial Assay {#S2.SS5}
-------------------

### Biological Assay Protocols {#S2.SS5.SSS1}

The test strains were acquired from the ATCC: ESBL-producing *Escherichia coli* (ATCC 35218), *Acinetobacter baumannii* (ATCC 19606), *Pseudomonas aeruginosa* (ATCC 15542), *Klebsiella pneumoniae* (ATCC 700603), methicillin-resistant *Staphylococcus aureus* (ATCC 43300), *Enterococcus faecalis* (ATCC 29212), and *Candida albicans* (ATCC 10231). The reference compounds for the tests were recommended by the National Committee for Clinical Laboratory Standards ([@B11]): vancomycin (Sigma, cat \#861987), amikacin (Sigma, St. Louis, United States; cat \#1019508), ceftriaxone (Sigma, cat \#1098184), and fluconazole (Sigma, cat \#1271700); all test compounds were ≥95% pure (HPLC, wavelength = 210 nm).

### Determination of the Minimum Inhibitory Concentrations {#S2.SS5.SSS2}

Determination of the minimum inhibitory concentrations (MICs) was conducted according to our previously reported broth microdilution method ([@B7]; [@B20]). In short, the inoculum was standardized to approximately 5 × 10^5^ colony-forming units/mL. The plates were incubated at 37 °C for 16 h, and the MIC values were recorded as the lowest concentration of antibiotic, at which no visible microbial growths were observed. Each experiment was performed three times.

### Statistical Analysis {#S2.SS5.SSS3}

GraphPad Prism 5.0 software (GraphPad, San Diego, United States) was used to carry out statistical analysis of the data. The data were expressed as the means ± SD. Values were analyzed with SPSS version 12.0 software (Softonic, Barcelona, Spain) by one-way analysis of variance, and *p* \< 0.05 was considered statistically significant.

Results and Discussion {#S3}
======================

The EtOAc extract of the solid medium of *Bipolaris* species TJ403-B1 was subjected to extensive chromatographic separations over silica gel column, RP-C~18~ gel column, Sephadex LH-20, and semipreparative HPLC to afford six previously undescribed ophiobolin-type sesterterpenes, namely, bipolatoxins A--F (**1**--**6**); and one previously undescribed pimarane-type diterpene, namely, 1β-hydroxy momilactone A (**7**); along with three known compounds (**8**--**10**).

Compound **1** was obtained as colorless needle crystals, and its molecular formula was assigned as C~25~H~38~O~3~, based on the HRESIMS data at *m*/*z* 409.2729 (\[M+Na\]^+^, calcd for C~25~H~38~O~3~Na^+^, 409.2713) in conjunction with the NMR data analyses, which was indicative of an index of hydrogen deficiency of seven. The ^13^C NMR data ([Table 3](#T3){ref-type="table"}) together with the DEPT spectrum of **1** showed a total of 25 resonances that could be assigned as five methyls, six methylenes (including one oxygenated), nine methines (including four olefinic), and five non-protonated carbons (including one ketone, one oxygenated, and two olefinic). Apart from four indices of hydrogen deficiency attributed to three double bonds (δ~C~ 183.1/130.6, 135.1/130.7, 126.3/140.6) and a carbonyl (δ~C~ 212.0), the remaining indices of hydrogen deficiency suggested that **1** has a tricyclic ring system.

Further analyses of the HSQC, ^1^H--^1^H COSY, and HMBC spectral data established an ophiobolin-type sesterterpene nucleus, structurally related to known ophiobolin Q ([@B3]) with the major differences being listed as follows: (a) the C-21 formyl group in ophiobolin Q was replaced by a hydroxylated methylene group (C-21, δ~C~ 67.0) in **1**; and (b) the disappearance of a hydroxylated methylene group (C-18) in ophiobolin Q and the double bond migrated from C-16/C-17 to C-17/C-18 in **1**. These conclusions were further supported by the ^1^H--^1^H COSY correlations ([Figure 2](#F2){ref-type="fig"}) of H-15 (δ~H~ 1.55)/H~2~-16 (δ~H~ 1.71 and 2.20)/H-17 (δ~H~ 5.60)/H-18 (δ~H~ 5.59) and HMBC correlations from H~3~-23 (δ~H~ 0.90) to C-14 (δ~C~ 52.0), C-15 (δ~C~ 33.6), and C-16 (δ~C~ 41.1) and from H~3~-24 (δ~H~ 1.26) to C-18 (δ~C~ 140.6), C-19 (δ~C~ 71.1), and C-25 (δ~C~ 30.1). The NOESY cross-peaks ([Figure 3](#F3){ref-type="fig"}) of H-6 (δ~H~ 3.61)/H-10 (δ~H~ 2.71)/H-14 (δ~H~ 1.84) and H-2 (δ~H~ 2.95)/H~3~-22 (δ~H~ 1.07) indicated that H-6, H-10, and H-14 were all on the same face with α orientations, whereas H-2 and H~3~-22 were β-oriented. However, for the configuration of C-15, it could not be defined by analysis of the NOE signals. Fortunately, a suitable crystal of **1** was obtained in MeOH--H~2~O (20:1, vol/vol) at room temperature and then subjected to a single-crystal X-ray diffraction experiment with Cu Kα radiation \[[Figure 4](#F4){ref-type="fig"}, Flack parameter = 0.08(3)\], which enabled us to establish its absolute configuration as 2*S*, 6*R*, 10*S*, 11*R*, 14*R*, and 15*S*, along with an *E* geometry of the Δ^17,18^ double bond. Accordingly, the structure of **1** was defined and named bipolatoxin A. Remarkably, our study further supports that during the cyclization of all ophiobolins AcOS favors a 1,5-H shift (C-8--C-15) to display the 15*S* configuration of the side chain ([@B4]; [@B15]).

![Key HMBC (red lines) and ^1^H--^1^H COSY (blue bold lines) correlations of compounds **1**--**7**.](fmicb-11-00856-g002){#F2}

![Key NOESY/ROESY correlations of compounds **1** and **4**--**7**.](fmicb-11-00856-g003){#F3}

![X-ray ORTEP drawings of compounds **1**, **4**, and **8**.](fmicb-11-00856-g004){#F4}

Compound **2** was obtained as a colorless oil, which had a molecular formula of C~26~H~40~O~3~, according to its HRESIMS data at *m/z* 423.2882 (\[M+Na\]^+^, calcd for 423.2870). The 1D NMR data ([Tables 1 and 3](#T1){ref-type="table"}) showed close similarities to those of **1**, except for the C-19 hydroxy group in **1** being replaced by a methoxy group (δ~C~ 50.5) in **2**, as supported by the key HMBC correlation ([Figure 2](#F2){ref-type="fig"}) from δ~H~ 3.14 (3H, s, OMe-19) to C-19 (δ~C~ 76.4). The close resemblance of the NOESY data ([Supplementary Data Sheet S5](#DS5){ref-type="supplementary-material"}) and experimental CD curves ([Figure 5](#F5){ref-type="fig"}) of **1** and **2** suggested their identical absolute configuration. Accordingly, the structure of **2** was defined and named bipolatoxin B.

![Experimental CD spectra of compounds **1**--**2** and **4**--**5**.](fmicb-11-00856-g005){#F5}

Compound **3** was also purified as a colorless oil. The HRESIMS analysis of **3** displayed a sodium adduct ion at *m/z* 407.2550 \[M+Na\]^+^ (calcd for 407.2557), suggesting a molecular formula of C~25~H~36~O~3~. Subsequent comparison of the ^1^H and ^13^C NMR data ([Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}) of **3** with those of **1** suggested that **3** contained an additional double bond (δ~C~ 121.1 and 151.2). Further analyses of the HMBC data ([Figure 2](#F2){ref-type="fig"}) of **3** revealed that the double bond was located between C-13 and C-14, as supported by the correlations from H~3~-23 (δ~H~ 1.09) to C-14 (δ~C~ 151.2) and from H-13 (δ~H~ 5.32) to C-10 (δ~C~ 52.1) and C-11 (δ~C~ 46.2). The stereochemical configuration of **3** was established to be the same as **1** by their closely resembled NOE data ([Supplementary Data Sheet S5](#DS5){ref-type="supplementary-material"}) as well as shared biogenesis. Accordingly, the structure of **3** was defined and named bipolatoxin C.

The HRESIMS ion at *m/z* 425.2653 (\[M+Na\]^+^, calcd for 425.2662), together with the ^13^C NMR and DEPT data for **4**, revealed its molecular formula to be C~25~H~38~O~4~, requiring an index of hydrogen deficiency of seven. The ^1^H and ^13^C NMR data ([Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}) of **4** closely resembled those of ophiobolin X ([@B21]), indicating that both compounds shared the same A/B/C rings and corresponding substituents, with the only difference being on the side chain that the conjugated double bonds (C-16/C-17 and C-18/C-19) were replaced by an sp^3^ methylene (δ~C~ 41.1, C-16), a double bond between C-17 (δ~C~ 127.0) and C-18 (δ~C~ 140.4), and a hydroxylated quaternary carbon (δ~C~ 71.1, C-19). These conclusions were further confirmed by the ^1^H--^1^H COSY correlations of H-14/H-15 (H~3~-23)/H~2~-16/H-17/H-18 and an obvious HMBC correlation from H~3~-24 to C-19 ([Figure 2](#F2){ref-type="fig"}). The ROESY correlations ([Figure 3](#F3){ref-type="fig"}) of H-5 (δ~H~ 4.99)/H-6 (δ~H~ 3.72)/H-2 (δ~H~ 2.05) and H~3~-20 (δ~H~ 1.21)/H-2 (δ~H~ 2.05)/H~3~-22 (δ~H~ 0.99)/H~3~-23 (δ~H~ 0.84) indicated that H-10 and H-14 were α-oriented, whereas H-2, H-5, H-6, H~3~-20, H~3~-22, and H~3~-23 were all β-oriented. After repeated recrystallization in MeOH--H~2~O (20:1, vol/vol) at room temperature, **4** furnished a crystal suitable for X-ray diffraction analysis ([Figure 4](#F4){ref-type="fig"}). The Flack parameter of 0.05(10) allowed an unambiguous assignment of the complete absolute configurations of all chiral centers as 2*S*, 3*R*, 5*S*, 6*S*, 10*S*, 11*R*, 14*R*, and 15*S*, as well as an *E* geometry of the Δ^17,18^ double bond. Accordingly, the structure of **4** was defined and named bipolatoxin D.

Compound **5** gave a molecular formula of C~25~H~36~O~4~, as assigned by a sodium adduct ion at *m/z* 423.2500 (\[M+Na\]^+^, calcd for 423.2506) in the HRESIMS analysis. Comparison of its 1D NMR data ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}) with those of **4** indicated that the double bond from C-17/C-18 in **4** migrated to C-18/C-19 in **5**, and an additional double bond (C-13, δ~C~ 125.9; C-14, δ~C~ 151.4) and an oxygenated methine (δ~C~/~H~ 84.6/4.23, C-12) were present, as supported by the ^1^H--^1^H COSY cross-peaks ([Figure 2](#F2){ref-type="fig"}) of H-12 (δ~H~ 4.23)/H-13 (δ~H~ 5.31), and H~2~-17 (δ~H~ 1.99)/H-18 (δ~H~ 5.15), together with HMBC correlations of H~3~-22 (δ~H~ 0.94) with C-12 (δ~C~ 84.6) and of H-18 with C-24 (δ~C~ 17.8) and C-25 (δ~C~ 25.9). Based on the ROESY correlation ([Figure 3](#F3){ref-type="fig"}) between H-10 (δ~H~ 2.28) and H-12, the hydroxy group at C-12 was determined to be β-oriented. The similar ROESY data ([Figure 3](#F3){ref-type="fig"}) and experimental CD curves ([Figure 5](#F5){ref-type="fig"}) of **4** and **5** indicated that both compounds shared the identical absolute configuration. Accordingly, the structure of **5** was defined and named bipolatoxin E.

Compound **6**, obtained as a colorless oil, gave a molecular formula of C~25~H~36~O~5~ via its (+)-HRESIMS data (*m/z* 439.2453, \[M+Na\]^+^, calcd for 439.2455). The ^1^H and ^13^C NMR data ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}) of **6** were similar to those of 21-dehydroophiobolin U ([@B21]), differing in that a ketone carbonyl, a double bond, and an aldehyde carbon signals were absent, and two carboxy groups (δ~C~ 172.1 and 173.4) and an additional oxygenated methine (δ~C/H~ 80.3/3.73) were present in **6**. The HMBC correlations ([Figure 2](#F2){ref-type="fig"}) of H-6 (δ~H~ 3.83) and H-8 (δ~H~ 6.41) with C-21 (δ~C~ 173.4) and of H~3~-24 (δ~H~ 1.82) and H-18 (δ~H~ 6.77) with C-25 (δ~C~ 172.1) suggested that two carboxy groups should be located at C-21 and C-25, respectively. The HMBC correlations from H~3~-23 (δ~H~ 0.89) to C-14 (δ~C~ 41.4), C-15 (δ~C~ 33.8) and C-16 (δ~C~ 37.1), together with the ^1^H--^1^H COSY cross-peaks of H-14 (δ~H~ 2.25)/H-15 (δ~H~ 1.78)/H~2~-16 (δ~H~ 1.30 and 1.41)/H~2~-17 (δ~H~ 2.25)/H-18 (δ~H~ 6.77), suggested that a C-16--C-17 double bond in 21-dehydroophiobolin U was reduced in **6**. The HMBC correlations from H-6 to C-2 (δ~C~ 155.4) and C-7 (δ~C~ 141.9) and from H-1 (δ~H~ 5.66) to C-6 (δ~C~ 41.8), C-10 (δ~C~ 47.3), and C-11 (δ~C~ 50.5) indicated that the double bond from C-2/C-6 in 21-dehydroophiobolin U migrated to C-1/C-2 in **6**. The ^1^H--^1^H COSY correlations of H-12 (δ~H~ 3.73)/H~2~-13 (δ~H~ 1.41 and 1.72)/H-14 suggested that an oxygenated methine at δ~C/H~ 80.3/3.73 was located at C-12. The NOESY correlations ([Figure 3](#F3){ref-type="fig"}) of H-6/H~3~-22 (δ~H~ 1.08), H-12/H-10 (δ~H~ 1.90)/H-14, and H-3 (δ~H~ 2.47)/H-1 (δ~H~ 5.66) indicated that the HO-12 group and H-6 were β-oriented, whereas H-10, H-14 and H~3~-20 were α-oriented. Accordingly, the structure of **6** was defined and named bipolatoxin F.

Compound **7** was isolated as a colorless oil, with the molecular formula of C~20~H~26~O~4~, as determined by its HRESIMS data (\[M+H\]^+^ ion peak at *m*/*z* 331.1913). Its ^1^H and ^13^C NMR data ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}) were similar to those of momilactone A ([@B8]), with the replacement of an sp^3^ methylene in momilactone A by an oxygenated sp^3^ methine (δ~C~/δ~H~ 68.2/4.18) in **7**, which was supported by analysis of its 2D NMR data ([Figure 2](#F2){ref-type="fig"}). In the ^1^H--^1^H COSY spectrum, the correlation of H-1 (δ~H~ 4.18)/H~2~-2 (δ~H~ 2.41 and 2.86), together with HMBC correlations from H-5 (δ~H~ 2.52) and H~3~-20 (δ~H~ 0.93) to C-1 (δ~C~ 68.2), suggested that a hydroxylated methine was located at C-1. In the NOESY spectrum ([Figure 3](#F3){ref-type="fig"}), the cross-peaks of H-1/H-5/H~3~-18 suggested that the OH-1 group should be β-oriented. Accordingly, the structure of **7** was established as shown and named 1β-hydroxy momilactone A.

The three known compounds were identified as 25-hydroxyophiobolin I (**8**) ([@B17]), ophiobolin I (**9**) ([@B17]), and ophiobolin A lactone (**10**) ([@B10]), by comparison of their NMR data and specific rotations with literature. Remarkably, it is the first time that the absolute structure of compound **8** was defined by the single-crystal X-ray diffraction analysis ([Figure 4](#F4){ref-type="fig"}).

Biological Evaluation {#S3.SS1}
---------------------

Because of the limited amount of compound **5**, only compounds **1**--**4** and **6**--**10** were evaluated for the antimicrobial activity against six drug-resistant microbial pathogens, including ESBL-producing *E. coli*, *A. baumannii*, *P. aeruginosa*, *K. pneumoniae*, methicillin-resistant *S. aureus* (MRSA), *E. faecalis*, and one fungus *C. albicans*. As shown in [Table 4](#T4){ref-type="table"}, except for compound **8**, all the other test compounds showed antimicrobial activity against certain microbial pathogens (MIC = 8--64 μg/mL), of which compound **4** showed significant inhibitory activity against *E. faecalis* with an MIC value of 8 μg/mL, and compound **10** showed significant inhibitory activity against *A. baumannii* and *E. faecalis* with MIC values of 8 and 8 μg/mL, respectively.

###### 

Antimicrobial activity of compounds **1**--**4** and **6**--**10**.

  Compounds     Minimum inhibitory concentrations (μg/mL)                                      
  ------------- ------------------------------------------- ------ ------ ------ ------ ------ ------
  **1**         ≥100                                        ≥100   32     ≥100   ≥100   ≥100   ≥100
  **2**         32                                          ≥100   ≥100   ≥100   64     16     ≥100
  **3**         32                                          32     ≥100   ≥100   ≥100   ≥100   16
  **4**         ≥100                                        ≥100   ≥100   ≥100   64     8      ≥100
  **6**         16                                          32     ≥100   32     ≥100   16     16
  **7**         64                                          ≥100   ≥100   ≥100   ≥100   ≥100   ≥100
  **8**         ≥100                                        ≥100   ≥100   ≥100   ≥100   ≥100   ≥100
  **9**         16                                          32     ≥100   32     ≥100   16     ≥100
  **10**        16                                          8      ≥100   32     32     8      ≥100
  Amikacin      4                                           2      2      8                    
  Ceftriaxone   8                                           8      2      2                    
  Vancomycin                                                                     0.5    0.5    
  Fluconazole                                                                                  1

a

ESBL

--E. coli

= ESBL-producing

Escherichia coli

ATCC 35218.

b

A. baumannii

=

Acinetobacter baumannii

ATCC 19606.

c

P. aeruginosa

=

Pseudomonas aeruginosa

ATCC 15542.

d

K. pneumoniae

=

Klebsiella pneumoniae

ATCC 700603.

e

MRSA = methicillin-resistant

Staphylococcus aureus

ATCC 43300.

f

E. faecalis

=

Enterococcus faecalis

ATCC 29212.

g

C. albicans

=

Candida albicans

ATCC 10231.

Conclusion {#S4}
==========

A total of 10 secondary metabolites (**1**--**10**), incorporating six new ophiobolin-type sesterterpenes (**1**--**6**) and one new pimarane-type diterpene (**7**), were isolated and identified from the solid cultures of fungus *Bipolaris* species TJ403-B1. The antimicrobial activity assay revealed that compound **4** showed significant inhibitory activity against *E. faecalis* with an MIC value of 8 μg/mL, and **10** showed significant inhibitory activity against *A. baumannii* and *E. faecalis* with MIC values of 8 and 8 μg/mL, respectively. Our current work not only replenishes new members to ophiobolin-type sesterterpenes, but also furnishes potential antimicrobial lead compounds that are necessary to check further for their synergistic and efflux pump inhibition properties.

Data Availability Statement {#S5}
===========================
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